MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C.
Mol Med Rep
; 13(1): 572-8, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26573417
ABSTRACT
Deregulation of microRNAs (miRNAs) is known to be associated with drug resistance in human cancers. However, the precise role of miR101 in the cisplatin (DPP) resistance of human gastric cancer cells has not been elucidated, yet. The present study revealed that miR101 was markedly downregulated in gastric cancer cell lines compared to that in the normal gastric mucosa epithelial cell line GES1. Furthermore, a significant decrease in miR101 levels, accompanied with an increased expression of vascular endothelial growth factor (VEGF)C in DDPresistant SGC7901 gastric cancer cells (SGC7901/DDP) compared with those in native SGC7901 cells was observed. In addition, forced overexpression of miR101 significantly inhibited cell proliferation, while enhancing cisplatininduced apoptosis of SGC7901/DDP cells. A luciferase reporter assay confirmed that VEGFC was a direct target of miR101 in SGC7901/DDP cells. Forced overexpression of miR101 in SGC7901/DDP cells reduced the expression of VEGFC, while knockdown of miR101 expression significantly enhanced VEGFC expression in SGC7901/DDP cells. Finally, overexpression of VEGFC inhibited DDPinduced apoptosis in SGC7901 cells. In conclusion, the results of the present study suggested that miR101 inhibited the proliferation and promoted DDPinduced apoptosis of DDPresistant gastric cancer cells, at least in part via targeting VEGF-C.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Cisplatin
/
Apoptosis
/
Drug Resistance, Neoplasm
/
MicroRNAs
/
Vascular Endothelial Growth Factor C
Limits:
Humans
Language:
En
Journal:
Mol Med Rep
Year:
2016
Document type:
Article